Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $622.48 million. The enterprise value is $402.41 million.
| Market Cap | 622.48M |
| Enterprise Value | 402.41M |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 59.12 million shares outstanding. The number of shares has increased by 13.45% in one year.
| Current Share Class | 59.12M |
| Shares Outstanding | 59.12M |
| Shares Change (YoY) | +13.45% |
| Shares Change (QoQ) | +1.84% |
| Owned by Insiders (%) | 1.25% |
| Owned by Institutions (%) | 67.88% |
| Float | 54.93M |
Valuation Ratios
The trailing PE ratio is 11.50 and the forward PE ratio is 18.51.
| PE Ratio | 11.50 |
| Forward PE | 18.51 |
| PS Ratio | 4.57 |
| Forward PS | 4.14 |
| PB Ratio | 2.87 |
| P/TBV Ratio | 3.00 |
| P/FCF Ratio | 51.90 |
| P/OCF Ratio | 48.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.57, with an EV/FCF ratio of 33.55.
| EV / Earnings | 7.65 |
| EV / Sales | 2.96 |
| EV / EBITDA | 4.57 |
| EV / EBIT | 4.65 |
| EV / FCF | 33.55 |
Financial Position
The company has a current ratio of 5.17, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.17 |
| Quick Ratio | 5.02 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.12 |
| Interest Coverage | 15.15 |
Financial Efficiency
Return on equity (ROE) is 34.80% and return on invested capital (ROIC) is 1,679.05%.
| Return on Equity (ROE) | 34.80% |
| Return on Assets (ROA) | 8.74% |
| Return on Invested Capital (ROIC) | 1,679.05% |
| Return on Capital Employed (ROCE) | 34.05% |
| Weighted Average Cost of Capital (WACC) | 10.08% |
| Revenue Per Employee | $2.23M |
| Profits Per Employee | $862,607 |
| Employee Count | 61 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 3.47 |
Taxes
In the past 12 months, ZVRA has paid $11.03 million in taxes.
| Income Tax | 11.03M |
| Effective Tax Rate | 15.91% |
Stock Price Statistics
The stock price has decreased by -6.40% in the last 52 weeks. The beta is 0.92, so ZVRA's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -6.40% |
| 50-Day Moving Average | 12.20 |
| 200-Day Moving Average | 10.10 |
| Relative Strength Index (RSI) | 40.88 |
| Average Volume (20 Days) | 1,486,129 |
Short Selling Information
The latest short interest is 7.80 million, so 13.19% of the outstanding shares have been sold short.
| Short Interest | 7.80M |
| Short Previous Month | 6.49M |
| Short % of Shares Out | 13.19% |
| Short % of Float | 14.19% |
| Short Ratio (days to cover) | 5.19 |
Income Statement
In the last 12 months, ZVRA had revenue of $136.07 million and earned $52.62 million in profits. Earnings per share was $0.92.
| Revenue | 136.07M |
| Gross Profit | 129.89M |
| Operating Income | 39.07M |
| Pretax Income | 69.29M |
| Net Income | 52.62M |
| EBITDA | 88.01M |
| EBIT | 86.52M |
| Earnings Per Share (EPS) | $0.92 |
Balance Sheet
The company has $221.57 million in cash and $1.50 million in debt, with a net cash position of $220.07 million or $3.72 per share.
| Cash & Cash Equivalents | 221.57M |
| Total Debt | 1.50M |
| Net Cash | 220.07M |
| Net Cash Per Share | $3.72 |
| Equity (Book Value) | 217.65M |
| Book Value Per Share | 3.67 |
| Working Capital | 202.67M |
Cash Flow
In the last 12 months, operating cash flow was $12.77 million and capital expenditures -$771,000, giving a free cash flow of $12.00 million.
| Operating Cash Flow | 12.77M |
| Capital Expenditures | -771,000 |
| Depreciation & Amortization | 1.49M |
| Net Borrowing | -60.09M |
| Free Cash Flow | 12.00M |
| FCF Per Share | $0.20 |
Margins
Gross margin is 95.46%, with operating and profit margins of 28.71% and 42.82%.
| Gross Margin | 95.46% |
| Operating Margin | 28.71% |
| Pretax Margin | 50.92% |
| Profit Margin | 42.82% |
| EBITDA Margin | 64.68% |
| EBIT Margin | 63.59% |
| FCF Margin | 9.81% |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.45% |
| Shareholder Yield | -13.45% |
| Earnings Yield | 8.45% |
| FCF Yield | 1.93% |
Analyst Forecast
The average price target for ZVRA is $25.00, which is 137.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.00 |
| Price Target Difference | 137.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 27.77% |
| EPS Growth Forecast (3Y) | 10.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 1:16.
| Last Split Date | Dec 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |